The state of Nebraska currently has 1 active clinical trials seeking participants for Diabetic Macular Edema research studies. These trials are conducted in various cities, including Omaha, Lincoln, Kearney and Grand Island.
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Recruiting
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander; in addition, a cohort of Asian Indian participants will be enrolled in India.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/03/2024
Locations: Stanley Truhlsen Eye Institute, Omaha, Nebraska
Conditions: Diabetic Macular Edema